Site Search
Spotlight on Test Utilization: Clinical Performance Comparison of FDA-Cleared HPV Tests
Originally published on May 14, 2013
Lecture Presenter
 | Robert Schlaberg, MD, MPH Medical Director, Microbial Amplified Detection, Virology, and Fecal Chemistry Laboratories |
Dr. Schlaberg is the medical director of the Microbial Amplified Detection, Virology, and Fecal Chemistry laboratories and an assistant medical director of the Molecular Infectious Disease laboratories at ARUP, as well as an assistant professor of clinical pathology at the University of Utah School of Medicine. He received his MD and doctor medicinæ degrees at the Julius-Maximilians-University in Wuerzburg, Germany and his master of public health at the Mailman School of Public Health at Columbia University in New York City, where he also served as a postdoctoral fellow. Dr. Schlaberg trained in clinical pathology at the Columbia University College of Physicians & Surgeons, where he was the chief clinical pathology resident. He is certified in clinical pathology and medical microbiology by the American Board of Pathology and was awarded the Young Investigator Award by the Academy of Clinical Laboratory Physicians and Scientists.
References
- Aptima HPV E6/E7 mRNA test is as sensitive as Hybrid Capture 2 Assay but more specific at detecting cervical precancer and cancer.
- Comparison of human papillomavirus testing strategies for triage of women referred with low-grade cytological abnormalities.
- Comparison of seven tests for high-grade cervical intraepithelial neoplasia in women with abnormal smears: the Predictors 2 study.
- Evaluation of oncogenic human papillomavirus RNA and DNA tests with liquid-based cytology in primary cervical cancer screening: the FASE study.
- Nucleic acid tests for the detection of alpha human papillomaviruses.
- Performance of the Aptima high-risk human papillomavirus mRNA assay in a referral population in comparison with Hybrid Capture 2 and cytology.
Sponsored by:
University of Utah School of Medicine, Department of Pathology, and ARUP Laboratories